PitchSend

Healthy Growth across all verticals in FY'22

FY'23 Road Map Capacity expansion: • • Lypholizer capacity increased to 3 folds in Beta drugs plant Separate lypholized injectable manufacturing facility for general injectable in Adley formulations plant (Cardiovascular, Antifungal, immunosuppressant) Barugs BETA DRUGS LTD. Domestic Market International market ΑΡΙ 5 New developments Plan to launch 4 new products FGMP accreditations Untapped market Improving PCPM Consolidate institutional business Geographical expansion Commercialization of products under registration Planning to file CEP by Oct 2022 New partnerships CMO Consolidating existing business New product addition with existing partners Partnership with 3 new Indian MNC

View entire presentation